Thousands of high-risk cancer gene variants identified
Over 5,000 genetic variants that enable certain cancers to thrive have been identified by scientists,…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Re-engineering cancerous tumours to self-destruct and kill drug-resistant cells
Treating cancer can sometimes feel like a game of Whac-A-Mole. The disease can become resistant…
Reversing chemotherapy resistance in pancreatic cancer
Pancreatic cancer is a particularly aggressive and difficult-to-treat cancer, in part because it is often…
Researchers map the effects of all potential changes in key cancer gene
Researchers at the Francis Crick Institute have mapped all the possible outcomes of changes to…
Noninvasive urine test for early detection of cervical cancer virus proteins
Cervical cancer is one of the most common cancers in women, with approximately 660,000 new…
Lymphoma patients at high risk of infections after diagnosis
Every year, around 100 people are affected by mantle cell lymphoma. A study at Uppsala…
Physician-scientist awarded two grants to develop immune therapies for ovarian cancer
Dr. Sanaz Memarzadeh, professor of obstetrics and gynaecology and molecular and medical pharmacology at the…
RNAs may help identify stage II colon cancer patients who may benefit from chemotherapy following surgery
The decision to treat patients with stage II colon cancer with adjuvant chemotherapy remains controversial.…
Novel liquid biopsy methodology enables the monitoring of disease evolution in patients with metastatic prostate cancer
Published in Cancer Cell, results of a study directed by Joaquin Mateo, Head of the…
How to stop cancer cachexia? Start at the top
When tumours elevate levels of an immune system molecule called Interleukin-6 (IL-6), it can cause…